Stockreport

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe [Yahoo! Finance]

AngioDynamics, Inc.  (ANGO) 
Last angiodynamics, inc. earnings: 4/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.angiodynamics.com/investor-relations
PDF ANGO has initiated the RECOVER-AV clinical trial, a prospective, multinational, single-arm study aimed at assessing the efficacy, safety and long-term outcomes of the Al [Read more]